Format

Send to:

Choose Destination
See comment in PubMed Commons below
South Med J. 2009 Aug;102(8):858-60. doi: 10.1097/SMJ.0b013e3181ad6078.

Recovery time in a case of gemfibrozil and simvastatin-associated rhabdomyolysis.

Author information

  • 1Department of Pharmacy Practice, Family and Community Medicine, Area Health Education Center-Northeast, University of Arkansas for Medical Sciences, Jonesboro, AR, USA. dcummins@ahecne.uams.edu

Abstract

Simvastatin is a cholesterol-lowering medication heavily prescribed to treat and prevent vascular disease. Despite widespread use, cases of simvastatin-induced rhabdomyolysis are rare. Little information is available regarding the recovery period for a patient who has experienced drug-induced rhabdomyolysis. We present a case involving a patient with multiple risk factors (advanced age, high-dose simvastatin therapy, concomitant nonsteroidal anti-inflammatory medication, and concomitant gemfibrozil therapy) and highlight his recovery course.

PMID:
19593291
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Southern Medical Association
    Loading ...
    Write to the Help Desk